Drug Type Universal CAR-T |
Synonyms CB 012, CB-012, CB012 |
Target |
Mechanism CLL-1 modulators(C-Type lectin domain family 12 member A modulators) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chronic Lymphocytic Leukemia | Phase 1 | US | 08 Feb 2024 | |
Refractory acute myeloid leukemia | Phase 1 | US | 08 Feb 2024 | |
Relapsing acute myeloid leukemia | Phase 1 | US | 08 Feb 2024 |